iShares Global Healthcare ETF (NYSEARCA:IXJ) Reaches New 52-Week High – Time to Buy?

iShares Global Healthcare ETF (NYSEARCA:IXJ) hit a new 52-week high on Monday . The stock traded as high as $103.42 and last traded at $103.25, with a volume of 48417 shares. The stock had previously closed at $102.28.

iShares Global Healthcare ETF Stock Down 0.4%

The firm has a market cap of $4.21 billion, a PE ratio of 21.58 and a beta of 0.56. The stock has a 50 day moving average price of $98.37 and a two-hundred day moving average price of $96.66.

Institutional Trading of iShares Global Healthcare ETF

Several large investors have recently bought and sold shares of IXJ. Nvest Wealth Strategies Inc. acquired a new stake in shares of iShares Global Healthcare ETF during the fourth quarter worth $30,000. Arax Advisory Partners acquired a new position in shares of iShares Global Healthcare ETF in the 4th quarter valued at $31,000. Franklin Resources Inc. raised its stake in iShares Global Healthcare ETF by 80.0% in the 2nd quarter. Franklin Resources Inc. now owns 360 shares of the company’s stock worth $31,000 after acquiring an additional 160 shares during the last quarter. LOM Asset Management Ltd raised its stake in iShares Global Healthcare ETF by 37.0% in the 4th quarter. LOM Asset Management Ltd now owns 407 shares of the company’s stock worth $40,000 after acquiring an additional 110 shares during the last quarter. Finally, Capital Investment Counsel Inc acquired a new stake in iShares Global Healthcare ETF during the 4th quarter worth about $42,000.

About iShares Global Healthcare ETF

iShares Global Healthcare ETF (the Fund), formerly iShares S&P Global Healthcare Sector Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the S&P Global 1200 Healthcare Sector Index (the Index). The Index measures the performance of companies that Standards & Poor’s Financial Services LLC (S&P) deems to be a part of the consumer staples sector of the economy. It is a subset of the S&P Global 1200 Index. Component companies include healthcare providers, biotechnology companies and manufacturers of medical supplies, advanced medical devices and pharmaceuticals.